FDA Adverse Event Malfunction Summary report: N

INRATIO

MDR report key: 3060907 · Received April 10, 2013

Report

Report Number
2027969-2013-00283
Event Type
Malfunction
Date Received
April 10, 2013
Date of Event
March 7, 2013
Report Date
April 10, 2013
Manufacturer
ALERE SAN DIEGO INC.
Product Code
GJS
PMA / PMN Number
K092987
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

DATA ANALYSIS PERFORMED ON INR RESULTS PROVIDED BY CUSTOMER. REVIEWED RETAIN TESTING ON REPORTED LOT 274167. OBSERVATIONS DISCREPANT RESULTS (ACCURACY) COMPARISON OF INRATIO TEST WITH LAB RESULTS PROVIDED BY END-USER AT TIME COMPLAINT WAS FILED: DATE: (B)(6) 2013, INRATIO METER = 4.6 INR, REFERENCE = 5.8 INR, MEAN = 5.20. THE MEAN IS >5.0 AND THE DIFFERENCE IS LESS THAN 2.2. AND ONLY ONE INR VALUE IS GREATER THAN 5.0. THESE RESULTS ARE CONSIDERED ACCURATE WITHIN THE CONTEXT OF THE DOCUMENTED VARIABILITY FOR INR TESTING. IN-HOUSE THERAPEUTIC DONOR TESTING HAS BEEN PERFORMED ON REPORTED LOT 274167 ON (B)(4) 2013. RESULTS AS FOLLOWS: (B)(4). ALL REPLICATES FOR EACH DONOR ARE WITHIN THE ACCEPTABLE BIAS FOR ACCURACY. PRODUCT PERFORMED AS EXPECTED. BOTH DONORS PRODUCED %CV LESS THAN (B)(4). ACCURACY AND PRECISION CRITERIA HAVE BEEN MET. NO FURTHER INVESTIGATION IS NECESSARY. CORRECTIVE ACTION IS NOT REQUIRED AT THIS TIME.

Description of Event or Problem · 1

CUSTOMER REPORTED DISCREPANT RESULTS COMPARED TO LAB RESULTS ARE AS FOLLOWS: DATE (B)(6) 2013, INRATIO: 4.6, LAB: 5.8. PATIENT'S THERAPEUTIC RANGE: 2-3. TIME BETWEEN EACH METHOD OF TESTING: 10 MINUTES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
148515 INRATIO PROTHROMBIN TIME TEST GJS ALERE SAN DIEGO INC. 100139 274167

Patients

Seq Age Sex Outcome Treatment
1 ONLY DIABETES TREATMENT| COUMADIN